Vanguard Group Inc Syros Pharmaceuticals, Inc. Transaction History

Vanguard Group Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.78 - $8.9 $2.25 Million - $25.7 Million	-2,882,608 Closed	0 $0
Q2 2022 Aug 12, 2022	BUY	$0.69 - $1.21 $432,683 - $758,764	627,078 Added 27.8%	2,882,608 $2.78 Million
Q1 2022 May 13, 2022	SELL	$1.02 - $3.8 $545,539 - $2.03 Million	-534,843 Reduced 19.17%	2,255,530 $2.69 Million
Q4 2021 Feb 14, 2022	SELL	$3.26 - $4.66 $637,672 - $911,519	-195,605 Reduced 6.55%	2,790,373 $9.1 Million
Q3 2021 Nov 12, 2021	BUY	$4.08 - $5.66 $858,440 - $1.19 Million	210,402 Added 7.58%	2,985,978 $13.3 Million
Q2 2021 Aug 13, 2021	BUY	$5.01 - $7.48 $13.9 Million - $20.8 Million	2,775,576 New	2,775,576 $15.1 Million

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $43.1M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.